In 1982, Borrelia burgdorferi sensu stricto (ss) was identified as the aetiological agent of Lyme disease. Since then an increasing number of Borrelia burgdorferi sensu lato (sl) species have been isolated in the United States. To date, many of these species remain understudied despite mounting evidence associating them with human illness. Borrelia bissettii is a spirochaete closely related to B. burgdorferi that has been loosely associated with human illness. Using an experimental murine infection model, we compared the infectivity and humoral immune response with a North American isolate of B. bissettii and B. burgdorferi using culture, molecular and serological methods. The original B. bissettii cultures were unable to infect immunocompetent mice, but were confirmed to be infectious after adaptation in immunodeficient animals. B. bissettii infection resulted in spirochaete burdens similar to B. burgdorferi in skin, heart and bladder whereas significantly lower burdens were observed in the joint tissues. B. bissettii induced an antibody response similar to B. burgdorferi as measured by both immunoblotting and the C6 ELISA. Additionally, this isolate of B. bissettii was sequenced on the Ion Torrent PGM, which successfully identified many genes orthologous to mammalian virulence factors described in B. burgdorferi. Similarities seen between both infections in this well-characterized murine model contribute to our understanding of the potential pathogenic nature of B. bissettii. Infection dynamics of B. bissettii, and especially the induced humoral response, are similar to B. burgdorferi, suggesting this species may contribute to the epidemiology of human borreliosis. 
INTRODUCTION
In 1982, the causative agent of Lyme disease was isolated from an Ixodes scapularis tick (Burgdorfer et al., 1982) . The bacterium, a spirochaete, was named Borrelia burgdorferi after Willy Burgdorfer, one of the researchers who identified it. Three decades after this discovery, advancements in molecular biology have led to the delineation of the B. burgdorferi sensu lato (sl) species complex (Stanek & Reiter, 2011) . This complex comprises, at the time of writing, 18 named species distributed around the globe (Kurtenbach et al., 2006; Margos et al., 2011) . While genetically similar, many of these bacteria occur in specific tick-vertebrate enzootic cycles (Gray et al., 2002) . Some vector ticks commonly contact humans (Estrada-Peña & Jongejan, 1999) , but many of these Borrelia enzootic cycles involve ticks that rarely bite humans, which subsequently leaves the pathogenicity of many B. burgdorferi sl species in question (Kiewra & Lonc, 2012; Margos et al., 2012) .
In 2011, 33 000 cases of human Lyme disease were reported to the Centers for Disease Control (CDC, 2011 ). Yet, recently the CDC has announced they estimate this statistic is well below the actual number of diagnosed cases (*300 000 year) (Hinckley et al., 2014) . Although seven B. burgdorferi sl species have been isolated in culture in North America only B. burgdorferi sensu stricto (ss) is widely considered responsible for cases of human Lyme disease (Stanek & Reiter, 2011) . One Borrelia species, Borrelia bissettii, is found overlapping the distribution of B. burgdorferi ss in the US and in areas of Europe (Margos et al., 2012) . The B. bissettii spirochaete is phylogenetically closely related to the human pathogenic B. burgdorferi ss species (Qiu & Martin, 2014) . To date, three studies have demonstrated molecular detection of B. bissettii (Girard et al., 2011; Rudenko et al., 2008 Rudenko et al., , 2009 in human clinical samples. Additionally, B. bissettii infection and pathology have been reported in laboratory animals (Eisen et al., 2003; Schneider et al., 2008) . Apart from these studies and general molecular surveys in ticks and wildlife (reviewed by Franke et al., 2013) , our understanding of B. bissettii, as well as most non-B. burgdorferi ss in the US, is still in its infancy.
Diagnosis of Lyme disease is an evolving field, often based on a combination of clinical signs (i.e. erythema migrans, facial palsy and major joint arthralgia), exposure to vector ticks in endemic areas and serological diagnostic tests (Aguero-Rosenfeld et al., 2005) . It is well recognized that B. burgdorferi sl spirochaetes cause a variety of clinical symptoms (Piesman & Gern, 2004; Rizzoli et al., 2011) , overlap geographically (Margos et al., 2011 (Margos et al., , 2012 and exhibit differential reactivity with current serological diagnostic tests (Branda et al., 2013; Norman et al., 1996) . Initial diagnostic tests (ELISAs and IgM/IgG immunoblots) were designed based on the B. burgdorferi ss organism; however, with our increased understanding of the genetic diversity of this species complex, many of these tests are proving to be less effective in their diagnostic abilities in areas where multiple Borrelia species are implicated in human disease (Dressler et al., 1994; Hauser et al., 1997 Hauser et al., , 1998a Norman et al., 1996) . This can be attributed to the highly diverse repertoire of Borrelia immunogenic proteins (Kenedy et al., 2012) ; ipso facto, studies have shown that utilization of multiple species in these serological tests greatly increases sensitivity (Hauser et al., 1998a, b; Norman et al., 1996) . If, in North America, additional B. burgdorferi sl spirochaetes have the potential to cause human infection, it is essential that we have a complete understanding of their infection course and induced immune response in wellcharacterized animal model systems.
In this study, we compare B. bissettii and B. burgdorferi ss infection in an experimental murine model. Both bacteria initiate remarkably similar infections in mice, elicit comparable antibody responses and possess orthologues to many known virulence-associated genes. The striking similarities between B. bissettii and B. burgdorferi ss infection and the immune response they elicit raise intriguing questions regarding B. bissettii pathogenicity in humans and its potential role in the epidemiology of Lyme borreliosis worldwide.
METHODS
Borrelia species. Low-passage (j5) Borrelia isolates utilized in this study included B. burgdorferi strain B31 (5A11) and B. bissettii strain CO275 (Maupin et al., 1994; Purser & Norris, 2000) . Both isolates were cultivated in Barbour-Stoenner-Kelly (BSK-H) complete (SigmaAldrich) medium supplemented with antibiotics as described by Barbour (1984) .
Murine infection. Initially, 6-week-old male C3H/HeJ (Jackson Laboratories) mice were randomly allocated to one of three groups of five mice. Intradermal inoculations were done in the caudoventral abdomen just right of midline with 10 6 mid-exponential-phase Borrelia. Groups were inoculated with B. bissettii, B. burgdorferi or BSK-H. Infection was allowed to develop for 4 weeks after which mice were killed. Blood (intracardiac) and tissues (skin, heart, bladder and joint) were taken for subsequent serology, culture and quantitative PCR (qPCR) analysis. Tissues were cultured as described by Sinsky & Piesman (1989) and monitored weekly for 8 weeks by dark-field microscopy for evidence of spirochaete growth. Three BALB/c SCID (Department of Laboratory Animal Medicine, Louisiana State University) mice were inoculated with B. bissettii culture as described above. After 3 weeks, mice were killed and tissues (ear punch, inoculation site and heart) were cultured as described by Sinsky & Piesman (1989) . Cultures were grown to mid-exponential phase and these host-adapted spirochaetes were utilized to repeat the experiment in C3H/HeJ mice and increasing the numbers of animals. All animal procedures were approved by Louisiana State University's Institutional Animal Care and Use Committee.
Genomic DNA (gDNA) extraction and qPCR. Mouse tissue samples were subjected to gDNA extraction using a GeneElute Genomic DNA Miniprep kit (Sigma-Aldrich) following the manufacturer's protocol. Extracts were stored at (20 uC until qPCR was performed. Primers and probes (Table 1) for B. burgdorferi and B. bissettii were developed based on known sequences of the decorin binding protein B (dbpB) gene located on lp54 (a single-copy linear plasmid essential for the Borrelia infectious cycle; NCBI accession nos. AE000790 and CP002761). Mouse primers and probes were adapted from those given by Grasperge et al. (2012) . qPCRs were set up in a 96-well plate; each reaction consisted of 17.5 ml of 2| Maxima Probe qPCR Master Mix (Thermo Scientific), 200 nM of each Borrelia dbpB primer and probe, 85 nM of each mouse cfd primer, 200 nM of mouse cfd probe, molecular biology grade water and 5 ml of template DNA. Reactions were transferred in triplicate 10 ml aliquots to 384-well plates for subsequent qPCR. Standard curves for quantification were based on 10-fold serial dilutions of single-copy gene plasmids assembled following the methods described by Zanetti et al. (2008) . qPCR was performed with a Roche Lightcycler 480i device. The ELISA. Individual infected mouse serum (diluted 1 : 200) was tested by C6 ELISA as previously described (Liang et al., 1999) . A TMB ELISA development kit (Kirkegaard & Perry Laboratories) was utilized according to the manufacturer's directions, and absorbance values were measured at 450 nm on an ELISA plate spectrophotometer. Cut-off absorbance was defined as the mean absorbance+3 SD of the negative control mice sera. All samples were assessed in duplicate and mean absorbance values are reported.
Lyme IgG immunoblots. Immunoblots of whole-cell B. burgdorferi B31 fractionated proteins were accomplished with a MarDx Marblot IgG kit (Trinity Biotech) following the manufacturer's instructions with minor modification. This included utilizing individual infected mouse serum as the primary antibody (1 : 200 dilution) followed by incubation with 1 : 1000 goat anti-mouse alkaline phosphatase labelled IgG (Kirkegaard & Perry Laboratories).
Characterization of B. bissettii (CO275) by next-generation sequencing. B. bissettii spirochaetes isolated from BALB/c SCID mice were subjected to next-generation sequencing on an Ion Torrent PGM platform utilizing a 316 chip, followed by de novo assembly with MIRA 4.0 (Chevreux et al., 1999) . Contigs generated were then aligned to the B. bissettii (DN127) reference chromosome (NC_015921) using Geneious version 7.1.2. The resulting contigs were deposited on the NCBI WGS server (Accession no. JNBW01000000; BioSample SAMN02768837). Protein coding regions (CDS) were identified and annotated by the NCBI Prokaryote Genome Annotation Pipeline (http://www.ncbi.nlm.nih.gov/genome/annotation_prok/). Because plasmid repertoire and content varies between Borrelia species and strains, non-chromosome contigs were aligned to the well-characterized B. burgdorferi B31 plasmids (NC_000948-000957, NC_001903-001904 and NC_001849-001857) and ORFs were predicted with the program GLIMMER (Delcher et al., 1999) . Geneious aligner was utilized for pairwise alignment and to compare known B. burgdorferi B31 mammalian-associated virulence determinants with predicted B. bissettii CO275 genes. 
RESULTS

B. bissettii is able to infect immunocompetent mice only after adaptation in immunodeficient mice
The initial infection study was performed by intradermal inoculation of C3H/HeJ mice with a single dose of 10 6 spirochaetes of B. bissettii (CO275) or B. burgdorferi (5A11) grown from frozen stocks. As shown in Table 2 , all five mice that were inoculated with B. burgdorferi were infected. In contrast, none of the mice that received B. bissetti produced a positive tissue, indicating that B. bissettii, at least in this phenotypic phase and form, is unable to infect immunocompetent mice (Table 2 ). This experiment was replicated utilizing BALB/c mice with identical results (data not shown).
This isolate of B. bissettii had been utilized and determined to be infectious to mice in a previous study (Schneider et al., 2008) . The loss of infectivity to mice seen in our initial needle challenge experiment may be the result of long-term storage (Grimm et al., 2003) . In an attempt to restore infectivity to this isolate, cultured B. bissettii was inoculated into BALB/c SCID mice. As shown in Table 2 , all tissues examined became positive 4 weeks post-inoculation (p.i.). Next, B. bissettii isolated from infected SCID mice was utilized to infect immunocompetent mice. Like mice that were inoculated with B. burgdorferi ss, all mice inoculated with host-adapted B. bissettii became infected (Table 2) , indicating that B. bissettii infectivity was restored after adaptation in immunodeficient animals. The original B. bissettii isolate used in this study was a low-passage stock culture, originally isolated from a Neotoma mexicana (woodrat) in Colorado, which had never been subcloned. Borrelia isolates from small mammals in the field contain highly heterogeneous (both genetically and phenotypically) populations of borreliae, and as demonstrated in this study, following long-term storage of this B. bissettii isolate immunocompetent animals were capable of clearing spirochaetes after needle challenge. However, passage through SCID mice allowed us to select for host-adapted infectious populations of the spirochaete that were subsequently able to infect immunocompetent animals (Anderson & Norris, 2006; Hofmeister et al., 1999) . B. bissettii infection results in similar bacterial burdens as B. burgdorferi ss in skin, heart and bladder tissues, but lower burdens in joint tissues Bacterial burdens were determined by qPCR to compare the ability of B. bissettii and B. burgdorferi ss to disseminate throughout and be retained in the tissues of infected animals. Tissues (skin, heart, urinary bladder and joint) were harvested for DNA extraction from 15 C3H/HeJ mice infected with B. bissettii (10 6 cells) and 10 mice infected with B. burgdorferi ss (10 6 cells) 4 weeks p.i. As shown in Fig. 1, B. bissettii infection led to similar bacterial burdens as B. burgdorferi ss infection in murine skin, heart and bladder tissues. However, B. bissettii burdens were significantly lower (Pj0.05) in joint tissues (Fig. 1) . Similarities in tissue bacterial burdens in most murine tissues support similar dissemination, measured 4 weeks p.i., between the two species.
B. bissettii infection elicits a similar murine antibody response as B. burgdorferi ss Serology is commonly utilized to diagnose borreliosis in both humans and animals. Murine infection models have been critical in the development and testing of these assays. We compared murine humoral immune response between B. bissettii and B. burgdorferi ss by two methods. First, convalescent serum from infected mice was subjected to a widely utilized commercial Lyme IgG immunoblot (Mardx Marblot). As shown in Fig. 2 , despite some differences, a similar banding pattern of immune reactivity was observed using serum from mice infected with B. bissettii and B. burgdorferi. Consistent with culture and qPCR results, when recommended diagnostic criteria were applied, each mouse was positive for infection by this assay. Because all B. burgdorferi sl species identified as agents of Lyme disease induce a strong C6 antibody response (Liang et al., 2000) , we also assessed the anti-C6 antibody response by ELISA to confirm results seen by commercial Western immunoblotting. As Fig. 3 shows, both B. bissettii and B. burgdorferi infection in mice elicited a similar anti-C6 antibody when measured by ELISA. Infection with both Borrelia species in this study elicited murine antibody responses to many common immunogenic proteins utilized in laboratory diagnostic tests. In this study murine B. bissettii infection was difficult if not impossible to distinguish from B. burgdorferi ss infection without additional species-specific testing. This would have direct implications in serological diagnosis especially as it relates to species specificity of certain diagnostic assays.
B. bissetti possesses many genes with high sequence similarity to major B. burgdorferi ss virulence-associated genes
The antibody response to the C6 epitope demonstrated that B. bissettii must possess a vlsE gene, although genomic data available for this species suggest a lack of such a gene . Notably, despite the genetic diversity of Borrelia species in the US, only B. burgdorferi ss has been demonstrated to harbour a vlsE gene. To gain Fig. 1 . B. bissettii infection generates similar bacterial loads to B. burgdorferi ss in skin, heart and bladder tissues, but lower spirochaete burdens in joint tissues. Twenty-five C3H/HeJ mice were inoculated with 10 6 spirochaetes of either host-adapted B. bissettii (n515) or infectious B. burgdorferi ss (n510) and killed 4 weeks p.i. Skin (inoculation site), heart, bladder and joint specimens were harvested for DNA extraction and analysed for tissue bacterial load by qPCR. (Table 3) . While not an exhaustive list, the presence of many of these well-described B. burgdorferi virulence-associated genetic orthologues in this infectious isolate of B. bissettii supports the infectious phenotype seen in this study.
DISCUSSION
Areas in Eurasia experience first-hand the complexity that multiple pathogenic Borrelia species can add to the epidemiology of human Lyme disease. With the advent of molecular technologies, our initial understanding of Lyme disease has drastically changed (Stanek & Reiter, 2011) . While these advances can work in our favour, one example being the ability to analyse the total transcriptome of B. burgdorferi ss during tick transmission and through host adaptation (Iyer et al., 2015) , in many ways they complicate the situation leaving, more often than not, additional questions. The idea of one spirochaete species, B. burgdorferi, being the sole cause of human Lyme disease was challenged in Europe. European cases of human borreliosis have clinical manifestations that present differently when compared with cases in the US (Nadelman & Wormser, 1998; Wang et al., 1999) . In addition, spirochaetes isolated in Eurasia from ticks and humans showed phenotypic differences from B. burgdorferi (Wang et al., 1999) . Eventually multiple Borrelia species, most notably Borrelia afzellii and Borrelia garinii, were identified as distinct spirochaete species capable of causing human illness throughout Eurasia (Stanek & Reiter, 2011 Subsequently, serological tests initially developed against North American B. burgdorferi ss were found to be less effective in detecting confirmed human borreliosis cases throughout Eurasia, which led to implementation of additional strategies for detection (Branda et al., 2013; Norman et al., 1996) .
The US, like Eurasia, has a diverse Borrelia fauna. While B. burgdorferi ss accounts for most human borreliosis cases (Bacon et al., 2008) (Margos et al., 2011 (Margos et al., , 2012 . In this study, we compared murine infection and antibody response to B. bissettii, a widespread yet understudied Borrelia spirochaete, and the widely studied human pathogenic B. burgdorferi ss.
Interestingly, we were unable to infect wild-type mice with the B. bissettii culture grown directly from low-passage frozen stock. Because this isolate had been utilized in a previous study and was successful in murine infection (Schneider et al., 2008) , we passaged the cultures through immunodeficient mice to determine if the virulence capacity of this isolate could be recovered. The isolate caused disseminated infection in SCID mice and re-isolated spirochaetes were successfully utilized to infect immunocompetent mice. This phenomenon had not previously been experienced in our laboratory, but loss of infectivity after long-term Borrelia storage has been described by at least one other research group (Grimm et al., 2003) . This isolate had been in cold storage for over 15 years. Similarly, virulence-associated plasmid loss has been described after long-term storage of Bacillus anthracis (Marston et al., 2005) . Unlike the direct transfer of host-adapted spirochaetes by tissue graft, we chose to utilize SCID mice to eliminate any spirochaete subpopulation in the original frozen culture stock incapable of murine infection. Subsequent cultures of SCID mouse tissues resulted in isolates capable of infection in both immunodeficient and immunocompetent mice. These resultant isolates would consist of clonally expanded populations of spirochaetes present in the original field isolate that were not subsequently eliminated by the innate immune system of the SCID mice. While this observation is interesting, the objective of this study was not to investigate the reason behind this; however, the exact mechanism does warrant further study and this phenomenon should be taken into consideration by researchers planning to utilize Borrelia isolates that have been stored for an extended period of time.
B. bissettii, like B. burgdorferi ss, causes similar pathology in murine hosts. This includes lymphocytic accumulations in the bladder interstitium, mononuclear cell infiltrates into great vessels and myocardium resulting in atrial inflammation and myocardial necrosis, and less commonly, mild inflammation and lesions in the femorotibial joint (Schneider et al., 2008) . Spirochaete burdens reported in our study support the pathological findings reported by Schneider et al. B. bissettii disseminates to various tissues and has similar spirochaete burdens to B. burgdorferi ss in the skin, heart and bladder, yet colonizes the joint tissues to a much lesser extent. Similar spirochaete burdens seen in both the bladder and the heart parallel pathology seen in murine models of both Borrelia infections and the decreased joint burdens described attest to the variable signs of joint pathology seen in the Schneider et al. B. bissettii pathology study (Schneider et al., 2008) . Spirochaete burden data also support evidence of human manifestations of B. bissettii infection, which includes reports of B. bissettii DNA detection in a cardiac tissue biopsy of a Lyme borreliosis case and, in multiple instances, human serum (Girard et al., 2011; Rudenko et al., 2008 Rudenko et al., , 2009 ). These findings, as well as the growing literature reporting the pathogenic potential of B. bissettii, suggest it may contribute to the epidemiology of human Lyme borreliosis, yet further investigation is warranted.
A vast amount of Lyme disease research focuses on developing better diagnostic tests for human infection. To date, the current serological diagnostic method recommended by the Infectious Disease Society of America consists of a two-tier approach (Wormser et al., 2006) . This two-tier test includes a Lyme whole-cell ELISA followed by an IgM/IgG immunoblot. An additional serological diagnostic test, the C6 ELISA, has been shown to be comparable with if not more reliable than the current two-tier testing approach (Bacon et al., 2003; Mogilyansky et al., 2004; Wormser et al., 2008) . Initial serological diagnostic tests were developed against one species, B. burgdorferi ss, of the B. burgdorferi sl complex. However, the expanding role of other species in human illness has led to tests, especially in Eurasia, which utilize multiple B. burgdorferi sl species/strains to facilitate increased detection. This approach has been shown to improve both sensitivity and specificity of these tests in areas endemic for multiple human pathogenic borreliae (Mavin et al., 2007; Robertson et al., 2000) . In this study, we investigated the ability of a Lyme IgG immunoblot and the C6 ELISA to detect infection in our B. bissettii murine model. Our results indicate that B. bissettii-infected mice had similar immunoblot results to mice infected with B. burgdorferi ss, particularly with regard to recognition of 'diagnostic' immune antigens. The fact that murine infections with B. bissettii elicit an antibody response that is cross-reactive with many B. burgdorferi ss antigenic proteins raises an intriguing question as to whether individuals diagnosed with Lyme disease, perhaps those that present with mild or no joint involvement, might be infected with B. bissettii rather than B. burgdorferi ss. The second test we evaluated was the C6 peptide ELISA test. It is based on a 26-mer amino acid peptide developed against an invariant region (IR6) of the well-studied virulence-associated outer surface VlsE protein (Liang et al., 1999) . This peptide was developed against the B. burgdorferi ss VlsE protein sequence but has been shown to be conserved among the three major pathogenic Borrelia species (B. burgdorferi ss, B. afzelii and B. garinii); additionally, during infection with these species, mice develop a strong anti-C6 antibody response (Liang et al., 2000) . In our study B. bissettii-infected mice elicited a similar anti-C6 antibody response to mice exposed to B. burgdorferi ss. This is the first report of a North American B. burgdorferi sl species other than B. burgdorferi ss eliciting a mammalian anti-C6 antibody response. Interestingly, a recent study (Millen et al., 2013) reported a follow up of canines in Colorado testing positive by a diagnostic C6 snap test. At least one canine had no history of travel to and/or residence in a Lyme endemic area, based on our finding that this animal may have been infected with B. bissettii, as northern Colorado is highly endemic for this Borrelia species (Schneider et al., 2000) .
With the advancement of next-generation sequencing technologies, the ability to identify genetic similarity between bacterial species is becoming easier, quicker and more cost effective. Because the only B. bissettii genome sequenced to date is lacking in description of a vlsE gene as well as any experimental infection data, we subjected our infectious isolate to next-generation sequencing in attempts to sequence the vlsE gene as well as other orthologues of known Borrelia mammalian virulence-associated genes. Sequencing confirmed the species identity of B. bissettii CO275 and revealed high pairwise sequence similarity with many major B. burgdorferi B31 hostassociated virulence genes. These findings support the phenotype seen in murine B. bissettii infection as well as the cross-reactivity of antibodies to many B. burgdorferi ss antigenic proteins. We were successful in obtaining near complete coverage of this isolate's chromosome and two conserved plasmids (cp26 and lp54), as well as high coverage of multiple additional plasmids (lp28-2, lp5 and cp9). The remaining contigs did align pairwise to additional B31 plasmids albeit at much lower coverage. However, because of the highly paralogous nature of Borrelia plasmids, B. burgdorferi sl plasmids comparisons even between strains remain highly problematic . Plasmids in the B. burgdorferi sl complex contain in excess of 600 kbp of additional DNA, with a large proportion of this genetic material containing Borrelia-specific hypothetical proteins with uncharacterized functions and pseudogenes Schutzer et al., 2011) . Because of this, much research is focused on defining the function of plasmid-borne genes especially as it relates to the bacterium's infectious cycle. It is well documented that plasmid retention has been shown to be critical to the infectivity of multiple B. burgdorferi strains; therefore, determining the plasmid repertoire of this isolate would help understand its potential to cause human illness. In this study we utilized a low-passag (P2) B. bissettii isolate obtained from a Neotoma mexicana and while a complete plasmid profile remains to be determined, orthologous mammalian-associated virulence genes, bacterial tissue burdens and murine antibody response to infection indicate bacteria with similar disease-causing potential. Studies to complete gaps in this draft genome and determining this isolate's plasmid profile are ongoing and once completed will facilitate more in-depth comparative genetic analyses.
These results confirm that B. bissettii has the ability to cause disseminated infections in mice (Eisen et al., 2003; Schneider et al., 2008) . To our knowledge, this is the first report comparing, side-by-side, B. bissettii and B. burgdorferi ss infection in the murine host. More importantly, we describe spirochaete burdens in multiple tissues and the first anti-C6 antibody response to a non-B. burgdorferi ss spirochaete in North America. These data also describe the ability of current serological tests to detect murine infection with B. bissettii. In mice, B. bissettii can cause a disseminated infection, and based on two serological diagnostic tests, elicits similar antibody profiles as observed in B. burgdorferi ss infections. While the murine model is the first step in determining infectivity of B. bissettii in mammals, it by no means implies these organisms are infectious to humans; however, there is growing evidence that B. bissettii may cause human and possibly canine illness. Current serological tests can detect B. bissettii infection yet are unable to distinguish between these two closely related spirochaetes. And while most tissues in both murine infections had similar bacterial burdens, a significantly lower burden of B. bissettii in the murine joint may indicate a milder disease course. A milder or atypical disease course in humans would complicate diagnosis; future studies should assess specific antigenic profiles shared by B. bissettii and B. burgdorferi ss to facilitate detection of specific Borrelia infections and the screening of human serum samples. More human-like animal models, such as the non-human primate model, could be used to determine what, if any, clinical signs B. bissettii infections would manifest in humans. The spectrum on Lyme disease is changing; to combat this global complex of emerging and potentially emerging bacterial infections, we must fully understand the scope of the problem. Future work should be directed at assessing the ability of each B. burgdorferi sl species' potential to cause illness in humans.
